Ignite Creation Date:
2025-12-24 @ 2:39 PM
Ignite Modification Date:
2025-12-24 @ 2:39 PM
Study NCT ID:
NCT06854159
Status:
RECRUITING
Last Update Posted:
2025-09-29
First Post:
2025-02-25
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Odronextamab for the Treatment of Relapsed and Refractory Diffuse Large B-cell Lymphoma Before and After Chimeric Antigen Receptor T-cell Therapy
Sponsor:
Joseph Tuscano
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-08-07
Start Date Type:
ACTUAL
Primary Completion Date:
2029-02-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-04
Completion Date Type:
ESTIMATED
First Submit Date:
2025-02-25
First Submit QC Date:
None
Study First Post Date:
2025-03-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-25
Last Update Post Date:
2025-09-29
Last Update Post Date Type:
ESTIMATED